Your browser doesn't support javascript.
loading
Thrombocytosis as a predictor of distant recurrence in patients with rectal cancer.
Cravioto-Villanueva, Adrian; Luna-Perez, Pedro; Gutierrez-de la Barrera, Marco; Martinez-Gómez, Hector; Maffuz, Antonio; Rojas-Garcia, Priscila; Perez-Alvarez, Claudia; Rodriguez-Ramirez, Saúl; Rodriguez-Antezana, Edgar; Ramirez-Ramirez, Lourdes.
Afiliação
  • Cravioto-Villanueva A; Colon and Rectum Service, Division of Surgical Oncology, Hospital de Oncologia, Centro Medico Nacional Siglo XXI, IMSS, Mexico City, Mexico. adriancravioto@mac.com
Arch Med Res ; 43(4): 305-11, 2012 May.
Article em En | MEDLINE | ID: mdl-22727694
BACKGROUND AND AIMS: Thrombocytosis is frequently observed in patients with malignancy. We undertook this study to determine the prognostic value of thrombocytosis in patients with rectal cancer. METHODS: We performed a retrospective study of patients undergoing low anterior resection for rectal cancer between January 2000 and March 2007. Preoperative platelet count was measured before surgery. Postoperative platelets were determined 1 month after surgery. Two-tailed p values <0.05 were considered statistically significant. RESULTS: One hundred sixty three patients with rectal cancer were included in the study. Preoperative platelet count >350,000 was found in 8% of patients. Postoperative platelet count >350,000 was found in 6% of patients. Distant metastases were found in 17 patients (10.4%). Significant variables in the multivariate analyses were preoperative platelets >350,000 (p = 0.001), postoperative platelets >350,000 (p = 0.002), carcinoembryonic antigen >13 ng/dL (p = 0.003). Patients with preoperative platelet count <350,000 showed a 5-year survival rate of 81%, whereas patients with platelet count >350,000 had a 25-month survival [95% confidence interval (CI): 20-26]; p <0.001. Patients with postoperative platelets <350,000 showed a 5-year survival rate of 80%, whereas patients with platelets >350,000 showed a 3-year survival rate of 37.5% (p <0.05). CONCLUSIONS: Pre- or postoperative platelet count >350,000 is associated with poor survival in patients with rectal cancer. The measurement of platelets is a clinical marker useful to define the prognosis for patients with rectal cancer.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Trombocitose / Carcinoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Mexico Idioma: En Revista: Arch Med Res Assunto da revista: MEDICINA Ano de publicação: 2012 Tipo de documento: Article País de afiliação: México País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Trombocitose / Carcinoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Mexico Idioma: En Revista: Arch Med Res Assunto da revista: MEDICINA Ano de publicação: 2012 Tipo de documento: Article País de afiliação: México País de publicação: Estados Unidos